Molecular Imaging 2017

PET-Plan: Endpoints

primary

local progression free survival

secondary

toxicity (CTC; RTOG/EORTC) doses to PTV reached by escalation

biometry

one-sided test; α=0,025, Power 80% primary analysis: non-inferiority secondary analysis: superiority of arm B